ALIGOS THERAPEUTICS INC

Aligos Therapeutics, a Nasdaq‑listed biotech, is developing breakthrough molecules to cure diseases, balancing volatile stock swings with a patient‑focused mission.

Aligos Therapeutics, a pioneering biotech company, is working to develop innovative molecules to cure diseases, driven by a commitment to innovation and a promise of a healthier tomorrow.